New tools to manage rare eye cancer
Findings from an international research study involving Irish and Spanish patients reveal a candidate drug and biomarker that could be used to manage uveal melanoma.
Feb 2, 2023
0
9
Findings from an international research study involving Irish and Spanish patients reveal a candidate drug and biomarker that could be used to manage uveal melanoma.
Feb 2, 2023
0
9
Considerable progress has been made to improve, extend, and save lives of patients with cancer in the last year, according to the 12th annual Cancer Progress Report released by the American Association for Cancer Research ...
Sep 21, 2022
0
8
Constitutively activated G proteins caused by specific mutations mediate the development of multiple malignancies. The mutated Gαq/11 are perceived as oncogenic drivers in the vast majority of uveal melanoma (UM) cases, ...
Sep 5, 2022
0
11